Plasmids Containing the T7 Promoter for High-Level Production of Eukaryotic Proteins in Prokaryotic Cells Read more about Plasmids Containing the T7 Promoter for High-Level Production of Eukaryotic Proteins in Prokaryotic Cells Canada2000368Filed on 1989-10-10
Nondenaturing Zwitterionic Detergents Read more about Nondenaturing Zwitterionic Detergents Switzerland82902934.7Filed on 1982-08-19
Nondenaturing Zwitterionic Detergents Read more about Nondenaturing Zwitterionic Detergents Luxembourg82902934.7Filed on 1982-08-19
Nondenaturing Zwitterionic Detergents Read more about Nondenaturing Zwitterionic Detergents The Netherlands82902934.7Filed on 1982-08-19
METHODS OF MAKING AND USING 7 a, 11 B-DIMETHYL-17 B- HYDROXY-4-ESTREN-3-ONE 17 B-TRANS-4-n-BUTYLCYCLOHEXANE CARBOXYLATE AND 7 a, 11 B-DIEMETHYL-17 B-HYDROXYESTR-4-EN-3-ONE 17-UNDECANOATE Read more about METHODS OF MAKING AND USING 7 a, 11 B-DIMETHYL-17 B- HYDROXY-4-ESTREN-3-ONE 17 B-TRANS-4-n-BUTYLCYCLOHEXANE CARBOXYLATE AND 7 a, 11 B-DIEMETHYL-17 B-HYDROXYESTR-4-EN-3-ONE 17-UNDECANOATE Japan2001-572528Filed on 2001-03-30
Methods Of Making And Using 7a, 11B-Dimethyl-17B-Hydroxy-4-Estren-3- One 17B-Trans-4-n-Butylcyclohexane Corboxylate And 7a 11B-Dimethyl... Read more about Methods Of Making And Using 7a, 11B-Dimethyl-17B-Hydroxy-4-Estren-3- One 17B-Trans-4-n-Butylcyclohexane Corboxylate And 7a 11B-Dimethyl... European Patent01922911.1Filed on 2001-03-30
PREPARATION AND USE OF ANDROGENIC COMPOUNDS Read more about PREPARATION AND USE OF ANDROGENIC COMPOUNDS Australia2001249661Filed on 2001-03-30
Utergolobin In The Treatment Of IgA Mediated Autoimmune Disorders Read more about Utergolobin In The Treatment Of IgA Mediated Autoimmune Disorders New Zealand515588Filed on 2001-11-20
Uteroglobin in The Treatment of IgA Meditated Automimmune Disorders Read more about Uteroglobin in The Treatment of IgA Meditated Automimmune Disorders European Patent00923335.4Filed on 2000-04-13
Utergolobin in The Treatment of IgA Meditated Automimmune Disorders Read more about Utergolobin in The Treatment of IgA Meditated Automimmune Disorders Canada2370738Filed on 2000-04-13